Podcasts about bcacp

Abby Frye, PharmD, BCACP, Clinical Pharmacy Specialist,Primary Care, Providence Medical Group, Providence St. VincentCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ywBS3NqHMf (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 9, 2025End Date: September 9, 2026

Abby Frye, PharmD, BCACP, Clinical Pharmacy Specialist,Primary Care, Providence Medical Group, Providence St. VincentCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ywBS3NqHMf (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 9, 2025End Date: September 9, 2026

Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You'll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.Special guests:Danielle Blais, PharmD, FCCP, BCCP, BCPSCardiology Lead Specialty Practice PharmacistRichard M. Ross Heart HospitalThe Ohio State University Wexner Medical CenterJoel C. Marrs, PharmD, MPH., BCACP, BCCP, BCPS, FAHA, FASHP, FCCP, FNLAProfessor and Coordinator of Clinical OutreachThe University of Tennessee Health Science CenterDepartment of Clinical Pharmacy & Translational ScienceYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in July 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Dual Antiplatelet Therapy for Coronary Artery DiseaseComparison of Oral Beta-BlockersAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsCholesterol Guidelines (United States)Non-Statin Lipid-Lowering AgentsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Celebrate the American Diabetes Association®'s (ADA) 85th anniversary with Drs. Neil Skolnik and Sara Wettergreen, joined by Dr. Marlon Pragnell, Charlene Wallace, and Stacey Krawczyk. Together, they'll reflect on the ADA's legacy of groundbreaking research and how it continues to shape the programs and resources available today. The conversation will also highlight practical tools—from nutrition guidance to the National Diabetes Prevention Program—to support you and your loved ones in managing or preventing diabetes. Because it all matters. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Charlene Wallace, MBA, Vice President of Diabetes Prevention at the ADA Stacey Krawczyk, MS, RD, Director of Nutrition and Wellness at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: Research Impact   Learn More About the National Diabetes Prevention Program    Eating for Diabetes Management   Diabetes Food Hub   More on the ADA's 85th Anniversary

In this episode of The Positive Pause®, host Claire Gill speaks with Dr. Adrienne Bitar, PhD and Dr. Jennifer Han, PharmD, BCACP, co-founders of Seen Nutrition about their personal experiences with bone health issues, including pre-menopausal osteoporosis, the important role of calcium in bone health & bone density, how to protect bone health at midlife, and the creation of their brand & its new calcium chew. Drawing from their personal and family experiences with osteoporosis, they created a food-first calcium chew, free of added sugars, synthetics, preservatives, and fillers, to help women protect their bones across all stages of life.Adrienne Bitar, PhD is a food studies researcher and lecturer in the Program in American Studies at Cornell University. She is the author of Diet and the Disease of Civilization (published by Rutgers University Press in 2018), a cultural history of diets in the US and analyzes how the obesity epidemic and diet book narratives reflect and shape broad cultural, religious, historical, and moral meaning. An expert in gender studies, food research, and the history of nutrition, Bitar has been widely consulted by journalists in the academic and popular press. Jennifer Han, PharmD is a Board-certified ambulatory care pharmacist (BCACP) practitioner at Syracuse Veterans Affairs Health System in New York, where she directs the chronic pain and whole health program. She has treated patients with full scope of practice to prescribe medications for chronic conditions such as diabetes, obesity, hypertension, dyslipidemia, pain and heart disease. Previously at Pomona Valley Hospital in Los Angeles, CA, Dr. Han created the first interdisciplinary clinical pharmacy practice at the Women and Family Medicine Clinic, as well as serving as clinical faculty of the Family Medicine Residency and residency coordinator for the Pharmacy Residency Program.Key Points CoveredPersonal Journeys & MotivationUnderstanding Bone Health Across the LifespanCalcium's Role in Bone HealthThe Problem with Traditional SupplementsPrevention & Early ActionPractical Advice for ListenersResources Available: Purchase your first order of the Seen Calcium Chew Complete - 1 Month Supply for only $35Bone Health and Osteoporosis Foundation (BHOF)International Osteoporosis Foundation (IOF)IOF Calcium CalculatorDr. Han and Dr. Bitar emphasize prevention, education, and smarter supplementation.  Start now, start small, and prioritize your bones for lifelong strength and mobility.Connect with Dr. Bitar and Dr. Han: Website LinkedIn: https://www.linkedin.com/company/seennutrition  https://www.linkedin.com/in/adriennerosebitar https://www.linkedin.com/in/jennifer-han-pharmd-bcacp  FacebookInstagram

ASHP's senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include: Leveraging pharmacists' expertise to advance HIV treatmentPharmacist roles in HIV care and management The current ART landscapeRegimen simplificationConsideration of patient preferences, health factors, and comorbidities for ART optimizationART management for treatment-experienced patients, including those with multidrug-resistant HIVPresenters:Alexis E. Horace, PharmD, BCACPProfessor of Pharmacy PracticeUniversity of Louisiana at Monroe College of PharmacyNew Orleans CampusCrescentCare Ambulatory Care Clinical Pharmacist, HIV SpecialtyNew Orleans, LouisianaNimish Patel, PharmD, PhD, AAHIVPProfessor of Clinical PharmacyDivision of Clinical PharmacySkaggs School of Pharmacy & Pharmaceutical SciencesUniversity of California, San DiegoLa Jolla, CaliforniaLink to full program: https://bit.ly/41agtqQGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In a conversation with CancerNetwork® at the 2025 National Immune Cell Effector Therapy (ICE-T) Conference, Tiba Al Sagheer, PharmD, BCOP, BCACP; Rebecca Gonzalez, PharmD, BCOP, FASTCT; and Syeda Saba Kareem PharmD, BCOP, spoke about their presentations on managing adverse effects (AEs) across different hematologic malignancy populations. At the meeting, Al Sagheer, Gonzalez, and Kareem presented their ideas for treating patients with lymphoma, leukemia, and multiple myeloma, respectively. Al Sagheer is a Pharmacy Quality Improvement Coordinator and Transplant/Cellular Therapy and Hematology Clinical Pharmacy Specialist at Miami Cancer Institute of Baptist Health South Florida. Gonzalez is a clinical pharmacy specialist in Blood and Marrow Transplantation and Cellular Immunotherapy at Moffitt Cancer Center. Kareem is a clinical pharmacy supervisor in Malignant Hematology at Moffitt Cancer Center. Across different disease states, the presenters outlined the most common toxicities associated with CAR T-cell therapy, bispecific antibodies, and other novel immunotherapies. Additionally, they described strategies for reducing the severity of AEs such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome as well as other oral, dermatological, and nail toxicities. Other key considerations for preserving quality of life among those receiving cellular therapy included risk stratifying patients based on tumor burden and inflammatory markers at baseline to inform prophylactic measures. Each presenter shared key takeaways for treating patients who experience treatment-related AEs based on their individual presentations. Al Sagheer emphasized that it is not “one size fits all” when it comes to therapy, as providers must tailor their use of specific drugs, prophylactic measures, and anti-infective medication to each individual patient. Kareem noted that cellular therapy represents an evolving field, as toxicity mitigation strategies will continue to change over time as new data emerge. Finally, Gonzalez underscored the intimate nature of the cellular therapy field, which presents opportunities to collaborate with other institutions and receive guidance on managing complex cases.  References Al Sagheer T. Mastering the management of adverse effects from cellular therapies in lymphoma. Presented at the 2025 National Immune Cell Effector Therapy (ICE-T) Conference; July 26, 2025; Orlando, FL. Gonzalez R. Navigating the challenges: managing adverse effects of cellular therapies in ALL. Presented at the 2025 National Immune Cell Effector Therapy (ICE-T) Conference; July 26, 2025; Orlando, FL. Kareem SS. Management of adverse events of CAR-T and T-cell engagers in myeloma. Presented at the 2025 National Immune Cell Effector Therapy (ICE-T) Conference; July 26, 2025; Orlando, FL.

Listen in as we explore the latest pharmacologic strategies for HIV prevention—before and after exposure. Our expert panel breaks down key considerations for PrEP and PEP, including indications, drug selection, dosing, and monitoring.Special guest(s):Caitlin Prather, PharmD, BCACP, AAHIVPClinical Pharmacy Specialist, Ambulatory CareInova Health SystemMichael A. Deaney, PharmD, AAHIVPInfectious Diseases Clinical PharmacistChildren's Hospital ColoradoYou'll also hear practical advice from TRC's Editorial Advisory Board member:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine - PhoenixFor the purposes of disclosure, Dr. Prather reports a relevant financial relationship [HIV PrEP] with Viiv Healthcare (speakers bureau).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in June 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Checklist: HIV Pre-Exposure Prophylaxis (PrEP)Checklist: HIV Postexposure Prophylaxis (PEP) ChecklistSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss the importance of insulin delivery and how advancements in this space are expected to improve diabetes outcomes.

Join Drs. Neil Skolnik and Sara Wettergreen as they discuss key takeaways from the ADA's 85th Scientific Sessions in Chicago, highlighting advancements in diabetes and obesity care. With guests, Drs. Osagie Ebekozien and Marlon Pragnell, they'll explore how these advancements can positively impact you and your loved ones.   Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Osagie Ebekozien, MD, MPH, CPHQ, Chief Quality Officer at the ADA  Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: Patient Standards of Care 2025 Need information on diabetes, ADA programs, or upcoming events? The ADA's Center for Information is here to help. Contact them directly at 1-800-DIABETES (1-800-342-2383) or email AskADA@diabetes.org for personalized guidance and support.

Artificial intelligence (AI) will bring many opportunities to the pharmacy profession, but it can be tempting to use AI in place of critical thinking or reliable research around drug information questions (DIQs). One must wonder, will the pharmacist be held liable if AI gets it wrong? Guest Authors: Elizabeth B. Hearn, PharmD, BCACP, CDCES; Karlyn E. Hood, PharmD, BCPS; Abigail L. Torres, PharmD Music by Good Talk

Join clinical experts Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, Madhuri M. Vasudevan, MD, MPH, FACE, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, to learn how the AACE Patient Journey of Diabetes Technology supports people with diabetes in navigating their treatment options with confidence. This patient-friendly resource, developed from AACE clinical guidelines and reviewed by Diabetes Sisters, a leading patient advocacy organization, provides clear and accurate information on diabetes technologies, from glucose monitors to insulin delivery devices. The experts also highlight how members of the endocrine care team are using this tool to empower people with diabetes to manage their journey. This episode is brought to you with the support of Abbott, Novo Nordisk, Medtronic, and Vertex.

Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTSarah Wheeler, PharmD, BCACP, CDCESAssistant ProfessorVCU School of PharmacyPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current terminology, risk factors, and stages associated with fatty liver disease.2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.0.05 CEU/0.5 HrUAN: 0107-0000-25-219-H01-PInitial release date: 6/23/2025Expiration date: 6/23/2026Additional CPE details can be found here.

Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTSarah Wheeler, PharmD, BCACP, CDCESAssistant ProfessorVCU School of Pharmacy Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current terminology, risk factors, and stages associated with fatty liver disease.2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.0.05 CEU/0.5 HrUAN: 0107-0000-25-219-H01-PInitial release date: 6/23/2025Expiration date: 6/23/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

 Tune in to this episode featuring Drs. Neil Skolnik and Sara Wettergreen as they explore the power of storytelling and how it brings us together. Special guests Marlee Seibold and Dr. Saige Kiedinger shared their personal experiences with type 1 diabetes, including— challenges, triumphs, and the everyday moments that have shaped their journeys. We hope that by listening to their stories, you'll gain a deeper understanding of the power of storytelling and feel inspired to share your own journey. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlee Seibold: Storytelling Communications Manager at the ADA and a person living with type 1 diabetes.   Dr. Saige Kiedinger: A recent pharmacy school graduate transitioning to residency training, also living with type 1 diabetes.   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Want to share your journey with us? Share it now here.

On this episode of The Huddle, Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES and Debbie Hinnen, APN, BC-ADM, CDCES, FAAN discuss the importance of medication persistence, how to talk to clients about starting and staying on diabetes medications, and strategies to help clients stay consistent with their medication taking. This episode was made possible with support from Lilly, A Medicine Company.Learn more about the latest in diabetes technology on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about the ADCES7 Self-Care Behaviors: Self-Care Tips (ADCES7)References:Kennedy-Martin, T., Boye, K. S., & Peng, X. (2017). Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Preference and Adherence, 11, 1103–1117. https://doi.org/10.2147/PPA.S136639McGovern, A., Hinton, W., Calderara, S. et al. A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes Ther 9, 229–242 (2018). https://doi.org/10.1007/s13300-017-0361-5Evans M, Engberg S, Faurby M, Fernandes JDDR, Hudson P, Polonsky W. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes Obes Metab. 2022; 24(3): 377-390. doi:10.1111/dom.14603Sabaté E., Adherence to Long-Term Therapies: Evidence for Action, 2003, World Health Organization, Geneva, Switzerland.https://www.ama-assn.org/delivering-care/physician-patient-relationship/8-reasons-patients-dont-take-their-medicationshttps://www.npr.org/sections/health-shots/2017/09/08/549414152/why-do-people-stop-taking-their-meds-cost-is-just-one-reasonhttps://www.adces.org/docs/default-source/handouts/adces7/handout_pwd_adces7_takingmedication.pdf?sfvrsn=4e3f6359_13 Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. In this episode ASHP sits down with Tammy McKinney, a patient living with diabetes and her pharmacist Tina Claypool of University of Louisville Health. Tammy, who is also a nurse, shares how Tina's expertise, dedication, and care improved her health and changed her life for the better.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy is evolving. Are independent pharmacies and pharmacy schools keeping up?    Ed Cohen and Traci Poole join us in this episode of the “Independent Rx Forum” to talk innovation, advocacy, and the push to redefine what it means to be a pharmacist today. From payment reform to public trust, let's turn talk to action.    To learn more about EmpowerRx, the program John Beckner mentioned that was created for pharmacy support staff by our Developing Opportunities committee, visit https://ncpa.org/empower-rx.   Guests:  Ed Cohen, PharmD, FAPhA, COO, PharmTeam Associates  Traci Poole, PharmD, BCACP, BCGP, FAPhA, director of community practice advancement, Belmont College of Pharmacy and Health Sciences, fellow, APhA

In this episode of This Week in Pharmacy for May 16th, 2025, Pharmacy Podcast Network founder Todd Eury is joined by his co-host Dr. Ryan Paul Liabenow, PhD, CEO of Mango Health as they review TWIRx News. Our first segment, we explore the transformative potential of the Long-Term Care at Home (LTC@Home) pharmacy model. As healthcare shifts towards home-based care, pharmacies have a unique opportunity to expand their services beyond traditional settings.  Key Discussion Points: Strategic Partnership Spotlight: We delve into the recent collaboration between RxSafe/Eyecon, PharmaComplete, and the LTC@Home Pharmacy Network. This alliance aims to revolutionize pharmacy operations through automation and expert consulting, enhancing patient care in the LTC@Home space. Expert Insights: Paul Shelton, founder of PharmaComplete and co-founder of the LTC@Home Pharmacy Network, shares his extensive experience in pharmacy operations and discusses strategies for pharmacies to successfully implement LTC@Home services. Automation in Focus: We examine how RxSafe's Eyecon technology, including RapidPakRx and RapidCardRx, is streamlining compliance packaging and improving workflow efficiency for pharmacies transitioning to the LTC@Home model.  Business Transformation: Learn how integrating LTC@Home services can lead to increased prescription volumes, enhanced patient outcomes, and new revenue streams for pharmacies. Why This Matters: The LTC@Home model represents a significant shift in pharmacy services, aligning with the broader trend of patient-centered, home-based care. By adopting this model, pharmacies can play a pivotal role in reducing hospitalizations and improving the quality of life for patients requiring long-term care.   On the second feature, we spotlight a remarkable family legacy that's shaped community pharmacy in Salt Lake City for over 70 years. We're talking about Jolley's Compounding Pharmacy—a third-generation, family-owned pharmacy that continues to blend tradition with innovation.   From the pioneering vision of Joel Jolley in 1954 to the modern leadership of Dean Jolley, R.Ph., and now Dr. Benjamin Jolley, the Jolley family has remained committed to personalized care, compounding excellence, and pharmacist-driven leadership. Ben is joined by his sister, Megan Jolley Milne, PharmD, BCACP, entrepreneur and CEO of Nutranize.    This Episode is sponsored by Independent Pharmacy Cooperative (IPC) and Eyecon RxSafe.    Connect with Us: For more insights and updates, follow This Week in Pharmacy on LinkedIn and Twitter.

Join Drs. Neil Skolnik and Sara Wettergreen in this episode as they discuss the importance of emotional wellbeing in overall health. They will explore the connection between mental health and diabetes, focusing on how managing a chronic condition can impact the emotional lives of people living with diabetes and their families. Special guest Dr. Kelsey Brzezinski will also join the conversation.   Please note that this episode includes discussions of sensitive topics, we encourage you to listen with care and understand that the American Diabetes Association® is not an organization that specializes in mental health and only seeks to bring awareness to factors that coincide with a diabetes diagnosis. If you are experiencing challenges seek the support of a licensed medical or mental health professional. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Kelsey Brzezinski, PhD, Pediatric Psychologist at Lurie Children's Hospital of Chicago, Assistant Professor of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine, Chicago, IL   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: If you or a loved one are experiencing a mental health crisis, please call the 988 Suicide & Crisis Lifeline. SAMHSA mental health help line, which is a no-cost, confidential, 24/7, 365-day-a-year treatment referral and information service available at 1-800-662-HELP (4357). Check out the American Diabetes Association®'s newly updated Mental Health Provider Directory to find to find therapists who specialize in supporting people living with diabetes near you.  

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they share tips to increase movement in honor of April being Move More Month. Since we're all about movement and exercise, we're excited to welcome special guests Adrienne Edge and David Rachal III from the American Diabetes Association®'s (ADA) Project Power program. They'll share how you can get involved and start moving to stay healthy, prevent, or better manage type 2 diabetes. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Adrienne Edge, Founder of ProFIT Family Wellness, Community Partner and Facilitator Trainer for the ADA's Project Power program   David Rachal III, Nationally Respected Leader in Medical Fitness, Wellness, and Entrepreneurial Empowerment, Community Partner and Facilitator Trainer for the ADA's Project Power program   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   To learn more about Project Power, be sure to check out: diabetes.org/ProjectPower.

Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after organ transplants. Optimal doses can vary by patient ethnicity and are key to successful transplantation.Speaker 3: (00:32) Could you provide us a with little bit about your background and yourself? Speaker 3: (03:45) Will you please provide a brief overview of Mayo test 3A5Q? Speaker 3: (06:56) Which patients should have this testing, and when should it be performed? Speaker 3: (08:15) What alternative or complementary tests should be considered? Speaker 3: (09:25)How are the results used in patient care? Speaker 3: (10:38)Will you help the audience understand the significance of monitoring tacrolimus levels for transplant rejection? Speaker 3: (12:53)What alleles are included in this test?

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss pharmacists' role in counseling patients on GLP-1s as well as the common trends, challenges, and successes she's seen among her patient population. 

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits.  We'll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.Special Guests:Lauren G. Pamulapati, PharmD, BCACPAssociate Professor, Ambulatory CareVirginia Commonwealth University School of PharmacyClinical Pharmacist, Hayes Willis Health Center/VCU HealthChristie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy PracticeDirector, PGY2 Ambulatory Care Residency ProgramMidwestern University College of Pharmacy, Downers Grove CampusClinical Pharmacist, Northwestern MedicineTRC Editorial Advisory Board Participant:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleFor the purposes of disclosure, Dr. Schumacher reports a relevant financial relationship [CGM for diabetes management] with Abbott (speakers bureau).The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in February 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Diabetes Medications: Cardiovascular and Kidney ImpactChart: Drugs for Type 2 Diabetes Algorithm: Stepwise Treatment of Type 2 DiabetesChart: Comparison of GLP-1 AgonistsToolbox: Improving Heart Failure CareSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence Educational Objectives Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management Explain patient education and counseling for managing hypercholesteremia Faculty: Joseph Saseen, PharmD, BCPS, BCACP, CLS Professor and Associate Dean for Clinical Affairs University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, Colorado   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Executive Director, Ambulatory Pharmacy Services Grady Health System Atlanta, Georgia Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following financial relationships with commercial interests to disclose: Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose: Grant/Research Support: Novartis Consultant: Novartis, Regeneron   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.   This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.   Please follow the link below to access this activity on PTCE and claim CE credit: www.pharmacytimes.org/hyperlipidemiapodcast

Hormone replacement therapy (HRT) remains a cornerstone of managing menopausal symptoms, but understanding the latest evidence is crucial for safe and effective use. This episode dives into evidence-based therapies, weighing benefits and risks and highlighting the pharmacist's role in guiding personalized care. Tune in to stay updated on the science behind HRT and its evolving role in patient care. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTAshley Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCPClinical ProfessorPurdue UniversityPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the latest evidence-based approaches to hormone replacement therapy (HRT) for managing menopausal symptoms.2. Identify key considerations for pharmacists when counseling patients on the benefits, risks, and appropriate use of HRT.0.05 CEU/0.5 HrUAN: 0107-0000-25-087-H01-PInitial release date: 3/31/2025Expiration date: 3/31/2026Additional CPE details can be found here.

Hormone replacement therapy (HRT) remains a cornerstone of managing menopausal symptoms, but understanding the latest evidence is crucial for safe and effective use. This episode dives into evidence-based therapies, weighing benefits and risks and highlighting the pharmacist's role in guiding personalized care. Tune in to stay updated on the science behind HRT and its evolving role in patient care.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTAshley Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCPClinical ProfessorPurdue University Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the latest evidence-based approaches to hormone replacement therapy (HRT) for managing menopausal symptoms.2. Identify key considerations for pharmacists when counseling patients on the benefits, risks, and appropriate use of HRT.0.05 CEU/0.5 HrUAN: 0107-0000-25-087-H01-PInitial release date: 3/31/2025Expiration date: 3/31/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence Educational Objectives Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management Explain patient education and counseling for managing hypercholesteremia Faculty: Joseph Saseen, PharmD, BCPS, BCACP, CLS Professor and Associate Dean for Clinical Affairs University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, Colorado   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Executive Director, Ambulatory Pharmacy Services Grady Health System Atlanta, Georgia Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following financial relationships with commercial interests to disclose: Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose: Grant/Research Support: Novartis Consultant: Novartis, Regeneron   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.   This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.   Please follow the link below to access this activity on PTCE and claim CE credit: www.pharmacytimes.org/hyperlipidemiapodcast

Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the differences between FDA-approved medications and compounded and counterfeit medications, alongside special guests Dr. Susan Kuchera and Lisa Kessler. They will explore the factors that might influence the decision to use compounded treatments, the risks associated with these treatments, and one of our guests will share their personal experience with obesity treatment. This episode of Diabetes Day by Day is supported by Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Kuchera, MD, Clinical Assistant Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University and Program Director of the Family Medicine Residency at Jefferson Health Abington   Lisa Kessler, MS, CCC-SLP, Infant-toddler Home-based Pediatric Speech-Language Pathologist   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! Learn more about the risks of buying medications online at the BeSafeRx website, the Food and Drug Administration's source for online pharmacy information. Read the American Diabetes Association®'s statement on compounded medications. 

Hypertension remains a leading contributor to cardiovascular disease, but advancements in its management are reshaping treatment strategies. This episode highlights the latest updates in hypertension guidelines, emerging therapies, and practical approaches pharmacists can use to optimize care. Don't miss this chance to stay informed and elevate your role in improving patient outcomes.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJoseph Saseen, PharmD, BCPS, BCACP, CLS, ASH-CHCProfessor and Associate Dean for Clinical AffairsUniversity of ColoradoPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent updates in hypertension management guidelines and their implications for patient care.2. Identify emerging therapies and evidence-based strategies pharmacists can use to optimize hypertension treatment and improve outcomes.0.05 CEU/0.5 HrUAN: 0107-0000-25-058-H01-PInitial release date: 3/10/2025Expiration date: 3/10/2026Additional CPE details can be found here.

Hypertension remains a leading contributor to cardiovascular disease, but advancements in its management are reshaping treatment strategies. This episode highlights the latest updates in hypertension guidelines, emerging therapies, and practical approaches pharmacists can use to optimize care. Don't miss this chance to stay informed and elevate your role in improving patient outcomes.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJoseph Saseen, PharmD, BCPS, BCACP, CLS, ASH-CHCProfessor and Associate Dean for Clinical AffairsUniversity of Colorado Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent updates in hypertension management guidelines and their implications for patient care. 2. Identify emerging therapies and evidence-based strategies pharmacists can use to optimize hypertension treatment and improve outcomes.0.05 CEU/0.5 HrUAN: 0107-0000-25-058-H01-PInitial release date: 3/10/2025Expiration date: 3/10/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Featured Guests: Brigid Groves, PharmD, MS  Mitch Rothholz, RPh, MBA, FAPhA Lucas Berenbrok, PharmD, MS, BCACP, FAPhA  ·              Key Takeaway: Knowing where patients can find vaccines at pharmacies is crucial to increasing convenient access.  

Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Over the Counter to discuss The Cut Hypertension Program, which operates in barbershops across the Bay Area in California. Zhou is the program's Lead Pharmacist and she is also an Associate Professor in the Department of Clinical Pharmacy at the University of California, San Francisco.

·              Featured Guests: Brigid Groves, PharmD, MS  Mitch Rothholz, RPh, MBA, FAPhA Lucas Berenbrok, PharmD, MS, BCACP, FAPhA  ·              Key Takeaway: Knowing where patients can find vaccines at pharmacies is crucial to increasing convenient access.

Objective: Discuss community-level strategies to engage individuals and special populations. ·              Topics Covered: o   Community outreach programs driven by pharmacists. ·              Unique to pharmacists and the pharmacy team is their ability to get outside of their 4 walls and bring vaccines and other healthcare services to where people are o   Central to many of these programs is support from government agencies and other payers – the availability of these resources in the future is unclear at this time. o   Utilization of Community Health Workers (CPESN/NCPA Health Care Worker / Technician program) §  There are pilots using codes that could be billed for this service.  Question is will money continue to be available §  Build on trust the public has with pharmacy team members – think about what other screening / preventive services you can incorporate with these trained individuals. - they can be ambassadors for your practice o   Addressing cultural and socioeconomic barriers to vaccine confidence. Connect with trusted community leaders Understand concerns from the populations your serve and who the influencers are with the community and family units Don't preach – provide credible information and let them process it o   Case studies of innovative engagement efforts, including partnerships with local organizations and faith-based groups. Offer to do talks Have discussion with organization leader and provide them with the facts they can use to reinforce messages o   How pharmacies can leverage their accessibility to serve as vaccination champions. Luke can talk about access; distance to pharmacies; pharmacy deserts Community health clinics, events, politicians events, etc. ·              Featured Guests: Brigid Groves, PharmD, MS  Mitch Rothholz, RPh, MBA, FAPhA Lucas Berenbrok, PharmD, MS, BCACP, FAPhA  ·              Key Takeaway: Collaboration with communi

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they dive into the world of mobile health technology and how it's shaping diabetes management. With so many apps for tracking blood glucose (blood sugar), counting carbs, and logging fitness activities, it can be tough to find the right one. In this episode, we welcome Susan Weiner, MS, RDN, CDCES, FADCES, a nutrition, health, and diabetes expert with knowledge of diabetes-related apps, and Bridget Wood, RD, LD, CDCES, who has lived with type 1 diabetes for over 15 years and has firsthand experience with apps that can assist with diabetes management. Our guests will share valuable insights on how apps can support people living with diabetes and why using them can be beneficial. This episode isn't sponsored, and we're not endorsing any specific app—just sharing examples of ones that have helped others. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Weiner, MS, RDN, CDCES, FADCES — Columnist at Endocrine Today, Owner of Susan Weiner Nutrition, PLLC, and Nutrition Communicator and Media Consultant, New York City Metropolitan Area Bridget Wood, RD, LD, CDCES — Owner and Clinical Director of Bridget Wood Wellness, LLC, Reno, NV Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! For additional resources, be sure to check out: FDA Alert DiabetesWise ADCES Danatech Apps and Platforms Phone apps referenced: Glucose Blood Sugar Tracker Dario Health Livongo by Teladoc Health mySugr Dexcom G7 Tidepool OMRON (for blood pressure)

Featured Guests Brigid Groves, PharmD, MS Mitch Rothholz, RPh, MBA, FAPhA Lucas Berenbrok, PharmD, MS, BCACP, FAPhA Key Takeaway Tools and techniques pharmacists can use to foster trust with patients regarding vaccines. CDC's "Vaccinate with Confidence" Initiative Protect Communities CDC is supporting partners to find and protect communities at risk through new investments and partnerships. Leverage CDC's Immunization and Vaccines for Children cooperative agreement to support efforts to identify and respond to areas with low vaccine coverage. Public trust in pharmacists and pharmacy teams helps reinforce vaccine messages. Collaboration with community leaders and influencers is crucial—messages must be evidence-based and credible. Best Practices for Pharmacists "Walk the talk"—if you or a family member received concomitant vaccines, share your experience. Example: "I received three vaccines at one visit (flu, COVID, and RSV), and I am here to talk about it (and I do)." Engage with patients by listening rather than lecturing. Acknowledge patient concerns and provide them with information to consider. Vaccine hesitancy is not the same as being anti-vaccine—many patients are "vaccine contemplators." Vaccine Effectiveness COVID-19 Vaccines Effectiveness Against Severe Outcomes Updated vaccines (September 2023 – January 2024) have been effective against XBB lineage and the new JN.1 variant. Waning Protection Booster doses are recommended as vaccine effectiveness declines over time. Population Variability Effectiveness varies based on age, underlying health conditions, and other factors (e.g., immunocompromised individuals may experience different levels of protection). General Vaccine Effectiveness Real-World Conditions Effectiveness is measured under real-world conditions, factoring in vaccine type, dosage, and timing. Monitoring & Updates The CDC continuously tracks vaccine effectiveness to adjust recommendations as needed. Impact of Vaccination Measles: Cases reduced from hundreds of thousands annually to only 49 in 2021. Polio: The U.S. has been polio-free since 1979. Hepatitis B: Routine vaccination significantly reduces liver cancer risk. Childhood Vaccinations: 100% reduction in cases of diphtheria, Hib, measles, mumps, polio, and rubella. Influenza incidence reduced by 17%. Overall Impact: Childhood immunizations have averted over 24 million cases of vaccine-preventable diseases in the U.S. Between 1994-2013, vaccinations prevented: 322 million cases of disease 21 million hospitalizations 732,000 deaths Public Health Strategies Use immunization data to identify areas of low vaccine coverage. Engage with local health departments to monitor vaccine-preventable disease trends. Strengthen immunization programs to enhance outbreak response. Encourage collaboration among healthcare providers—it shouldn't matter who vaccinates, the goal is increasing immunization rates. Empowering Families CDC is partnering with key organizations to strengthen vaccine conversations between providers and parents. Strategies Start vaccine conversations early, targeting parents of infants and pregnant women. Reduce hesitancy and improve access in community health centers. Develop provider toolkits to address parental concerns during outbreaks. Combating Misinformation CDC is working with local messengers and partners to stop vaccine myths. Challenges & Key Messages New administration statements have increased vaccine doubts, making conversations harder. There is no link between vaccines and autism, diabetes, or other diseases. Investments in Public Trust: Work with social media companies to promote trustworthy vaccine information. Provide accessible, accurate vaccine data to policymakers. Engage state and local health officials to counter misinformation effectively. Priorities for 2020 and Beyond CDC aims to ensure that every community is protected through: Data-driven strategies to identify vulnerable populations. Expanding local resources to strengthen vaccination efforts. Building a culture of immunization in healthcare settings. Improving public communication on vaccines. Enhancing partnerships to promote immunization initiatives. Ten Key Messages for Pharmacists Engaging with Vaccine-Hesitant Individuals Vaccines Save Lives – They prevent serious diseases and save millions of lives each year. Rigorous Testing – Vaccines undergo extensive trials and continuous monitoring to ensure safety and effectiveness. Community Immunity – Vaccination protects those who cannot be vaccinated, such as infants and immunocompromised individuals. Combating Misinformation – Rely on credible sources for vaccine facts. Misinformation fuels fear and hesitation. Mild Side Effects – Most side effects (e.g., sore arm, mild fever) are temporary. Severe side effects are extremely rare. Consult Healthcare Providers – Encourage patients to ask healthcare professionals for reassurance. Vaccines and Fertility – There is no evidence that vaccines, including COVID-19 vaccines, affect fertility. Herd Immunity – High vaccination rates protect entire communities. Rapid Vaccine Development Explained – COVID-19 vaccines were developed quickly due to unprecedented funding and collaboration—without compromising safety. Long-Term Benefits – Vaccination prevents future outbreaks and contributes to long-term public health. Pharmacists' Role in Addressing Hesitancy Provide accurate, evidence-based information. Listen actively to patients' concerns. Engage with community health workers to strengthen local vaccination efforts.

A new year brings a new episode of Diabetes Day by Day! Join Drs. Neil Skolnik and Sara Wettergreen as they provide an overview of the ADA's Standards of Care in Diabetes—2025 and discuss their significance. They will also explore new updates you can bring up with your primary care provider during your next visit, including recommendations for using diabetes technology, weight management strategies, including medication therapy, and the latest insights on nutrition.  Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the topic of heart failure. They'll discuss steps you can take if you're living with diabetes to prevent it or detect it early, and receive timely treatment for better outcomes.  In this episode, we welcome guest Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research. Dr. Januzzi has published more than 900 manuscripts, edited 5 textbooks, and serves as a Deputy Editor at the Journal of the American College of Cardiology. He is a nationally recognized lecturer on the testing and treatment of heart failure. Dr. Januzzi will share valuable insights to help people living with diabetes, no matter where they are in their journey, as it relates to heart health and heart failure.  This episode of Diabetes Day by Day is supported by Roche. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!  

Accountable Care Organizations (ACOs) have made great strides in enhancing patient care and reducing costs, saving $3.1 billion in 2023. The recently released report based on ACO performance in 2023 (PY2023) provides valuable insights into where ACOs are excelling. In this episode of Value-Based Care Insights, Dan Marino sits down with Sarah Kachur PharmD, MBA, BCACP, Executive Director of Strategy and Solutions at Johns Hopkins Population Health Analytics, to discuss the key findings of the report and what they reveal about the future of ACOs. Gain insights into the priorities of the most successful ACOs (in PY 2023) and their predictions for changes and challenges in 2025 and beyond. LinkedIn https://www.linkedin.com/in/sarahgracekachur/ Skachur2@jh.edu Hopkins ACGs: https://www.hopkinsacg.org/ Illustra Health from Johns Hopkins: https://illustra.health/

Ep 117 - Sarah Kachur- ACOs Saved Billions in 2023: Can They Sustain This Beyond 2025? Accountable Care Organizations (ACOs) have made great strides in enhancing patient care and reducing costs, saving $3.1 billion in 2023. The recently released report based on ACO performance in 2023 (PY2023) provides valuable insights into where ACOs are excelling. On this episode Dan sits down with Sarah Kachur PharmD, MBA, BCACP, Executive Director of Strategy and Solutions at Johns Hopkins Population Health Analytics, to discuss the key findings of the report and what they reveal about the future of ACOs. Gain insights into the priorities of the most successful ACOs (in PY 2023) and their predictions for changes and challenges in 2025 and beyond. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Electronic cigarettes (e-cigarettes; also known as e-cigs, electronic nicotine delivery systems, vapes, mods, pods, and vape pens) have surged in popularity since their market introduction in 2007. Some view e-cigarettes as a less harmful alternative to traditional cigarettes and a potential harm reduction strategy. Others worry about their addictive potential and see them as a setback in our quest for a tobacco-free society. Guest Authors: Elizabeth S. Yett, PharmD, BCACP, CTTS and Kirk E. Evoy, PharmD, BCACP, BC-ADM, CTTS Music by Good Talk

Asthma and chronic obstructive pulmonary disease (COPD) are underdiagnosed due to the underuse of spirometry, underreporting of symptoms, and economic barriers.  Is there an effective way to capture undiagnosed but symptomatic patients and route them for appropriately managing their respiratory symptoms?  That's what the UCAP study attempted to answer. Guest Authors:  Michelle Balli, PharmD, BCACP and Michelle Hernandez, PharmD Music by Good Talk

November marks American Diabetes Month®, and we're thrilled to share a new episode of Diabetes Day by Day! Join Drs. Neil Skolnik and Sara Wettergreen as they explore how gratitude, self-compassion, and resilience with an abundance mindset can empower you to thrive on your diabetes journey. We're also excited to welcome back guests Marina Chaparro, RD, CDCES, MPH, founder of Nutrichicos, a bilingual nutrition practice focusing on children and family nutrition, and Aaron Sutton, LCSW, Behavioral Health Consultant at the Family Medicine Residency Program, Abington Jefferson Health. They will be sharing their insights and personal stories with us. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marina Chaparro, RD, CDCES, MPH, Founder of Nutrichicos Aaron Sutton, LCSW, Behavioral Health Consultant, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Despite advances in the management of acute myocardial infarction (MI), up to 38% of patients will experience signs of heart failure (HF) and many have a reduced left ventricular ejection fraction (LVEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented cardiovascular benefits. However, data are limited regarding their use after an acute MI. Guest Authors: Amy Hu, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP, CDCES Music by Good Talk

On this episode of the Astonishing Healthcare podcast, four women pharmacists across Capital Rx's teams join host Justin Venneri to celebrate #WPD2024! Amy Stockton, PharmD (our guest for Episode 6); Symara Schmidt, PharmD, BCGP; Lauren Carroll, PharmD, BCACP; and Marissa Miller, PharmD, discuss the significance of Women Pharmacist Day and highlight the progress women have made in the pharmacy field and how and why they are celebrating this unique holiday within American Pharmacists Month. The conversation highlights personal stories about their careers, including advice they'd share with their younger selves, how they balance their roles at work and home, the importance of mentoring the next generation of women pharmacists, the impact pharmacists have on patient care, and their hopes for the future!Related ContentAH006 - Pharmacy Benefits 101: Clinical Care Teams, with Amy Stockton, PharmDAH025 - Empowering Pharmacists, with NASPA's Krystalyn Weaver, PharmD, JDFor more information about Capital Rx and this episode, please visit Capital Rx Insights.

It is still difficult for patients to quit despite their best efforts. Of the nearly 70% of current smokers who want to quit smoking, only about 7.5% succeed.  Unfortunately, there is a lack of evidence to inform subsequent treatment strategies if the initial quit attempt is unsuccessful. Guest Authors:  Elizabeth Yett, PharmD, BCACP, TTS and Katherine Montag Schafer, PharmD, BCACP, CDCES Music by Good Talk

Dr. Brooke Griffin, founder of Bold Idea Group, shares her career journey in pharmacy academia to launching her own coaching business.  This episode is brought to you by First Horizon. Summary In this inspiring episode, Tim Ulbrich introduces Dr. Brooke Griffin, a coach, mentor, and founder of Bold Idea Group. Dr. Griffin shares her career journey in academia to eventually launching her own business, and opens up about the challenges and triumphs of her path, including the bold steps she took and valuable lessons she has learned along the way.  This conversation is packed with practical wisdom for anyone seeking career fulfillment and personal growth. Whether you're just starting your career or looking to make meaningful changes, Dr. Griffin's journey and insights are sure to inspire you to take bold steps toward your own growth. About Today's Guest Brooke Griffin, PharmD, BCACP is a Professor of Pharmacy Practice and Vice Chair of Clinical Services at Midwestern University College of Pharmacy, Downers Grove. With over 20 years of experience in various ambulatory care clinics, she has worked on several multidisciplinary teams and precepted hundreds of students and residents. She is a Professional Coach in Life & Work and is passionate about offering career support through a thought-provoking and creative process. She is a coach and mentor through several pharmacy organizations and speaks nationally on various professional development topics, including the importance of coaching and mentoring, time management, and work/life integration. In 2022 she launched Bold Idea Group with a mission to inspire bold ideas from within. Her motivational podcast, Today's Bold Idea, offers a five minute inspirational boost to start your day. She is on this self-development journey alongside all of you and believes “every pharmacist deserves a coach.” Mentioned on the Show First Horizon Pharmacist Home Loan “Aliquot Investing: Small Investments in Big Real Estate Deals” Webinar on October 7th at 9pm/Eastern  Griffin B, Vest K, Pohl S, Mazan J, Winkler S. Part-time and job-share careers among pharmacy practice faculty members. Am J Pharm Educ. 2014 Apr 17;78(3):49. Destruct Yourself Podcast with Whitney Johnson Bold Idea Facebook Group Brooke Griffin LinkedIn Bold Idea Group  Today's Bold Idea Podcast  The Pharmacist's Voice®  Looking for other episodes on pharmacist businesses or side hustles? Episode 352: Pharmacy Innovators with Kelley Carlstrom, PharmD, BCOP Episode 307: Pharmacy Innovators with Dr. Izabella Wentz (The Thyroid Pharmacist) Episode 327: Pharmacy Innovators with Dr. Natalie Park (Pharmesol) Episode 289: Building Pricklee with Pharmacy Entrepreneur Kun Yang Episode 287: Monetizing Your Clinical Expertise with Dr. Timothy Gauthier YFP Disclaimer Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn YFP on Instagram YFP Facebook Group

Reason for Visit: The patient is a 76-year-old Hispanic referred to the ambulatory care pharmacist for dyslipidemia management.  The patient has a remote history of an MI (15 years ago) but states he is unable to take statins. Guest Authors: Mayela Warner, PharmD and Maricar Conson, PharmD, BCPS Expert Panelists: Sara Wettergreen, PharmD, BCACP, BC-ADM and Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, CDCES Music by Good Talk